Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Nitric Oxide innovations LLC, (NOi) is positioned to advance patented nitric oxide (NO) science into new and innovative therapies for human disease across different markets. The worldwide market involving NO-based therapies was $70 billion in 2018 and is projected to rise to $125 billion in 2023 and $195 billion in 2028 as new NO drugs are introduced into the market. Future prospects for NO-based therapies are bright and fit i...
Nitric Oxide innovations LLC, (NOi) is positioned to advance patented nitric oxide (NO) science into new and innovative therapies for human disease across different markets. The worldwide market involving NO-based therapies was $70 billion in 2018 and is projected to rise to $125 billion in 2023 and $195 billion in 2028 as new NO drugs are introduced into the market. Future prospects for NO-based therapies are bright and fit in with biotechnology-based approaches to modern drug discovery and development. It is anticipated that some of these products will help in meeting the unfulfilled needs in human therapeutics.

List your booth number for exhibitions, ask us